Literature DB >> 16474132

Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.

Subhash C Verma1, Tathagata Choudhuri, Rajeev Kaul, Erle S Robertson.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) DNA persists in latently infected cells as an episome via tethering to the host chromosomes. The latency-associated nuclear antigen (LANA) of KSHV binds to the cis-acting elements in the terminal repeat (TR) region of the genome through its carboxy terminus. Previous studies have demonstrated that LANA is important for episome maintenance and replication of the TR-containing plasmids. Here we report that LANA associates with origin recognition complexes (ORCs) when bound to its 17-bp LANA binding cognate sequence (LBS). Chromatin immunoprecipitation of multiple regions across the entire genome from two KSHV-infected cell lines, BC-3 and BCBL-1, revealed that the ORCs predominantly associated with the chromatin structure at the TR as well as two regions within the long unique region of the genome. Coimmunoprecipitation of ORCs with LANA-specific antibodies shows that ORCs can bind and form complexes with LANA in cells. This association was further supported by in vitro binding studies which showed that ORCs associate with LANA predominantly through the carboxy-terminal DNA binding region. KSHV-positive BC-3 and BCBL-1 cells arrested in G(1)/S phase showed colocalization of LANA with ORCs. Furthermore, replication of The TR-containing plasmid required both the N- and C termini of LANA in 293 and DG75 cells. Interestingly, our studies did not detect cellular ORCs associated with packaged viral DNA as an analysis of purified virions did not reveal the presence of ORCs, minichromosome maintenance proteins, or LANA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474132      PMCID: PMC1395374          DOI: 10.1128/JVI.80.5.2243-2256.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions.

Authors:  R Renne; M Lagunoff; W Zhong; D Ganem
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Lagunoff; D Ganem
Journal:  Virology       Date:  1997-09-15       Impact factor: 3.616

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

Authors:  M A Cotter; E S Robertson
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

6.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

7.  Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.

Authors:  Ke Lan; Daniel A Kuppers; Subhash C Verma; Nikhil Sharma; Masanao Murakami; Erle S Robertson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA.

Authors:  Andrew Godfrey; John Anderson; Antigoni Papanastasiou; Yasu Takeuchi; Chris Boshoff
Journal:  Blood       Date:  2004-11-30       Impact factor: 22.113

9.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

10.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

View more
  69 in total

1.  Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.

Authors:  Jie Lu; Masanao Murakami; Subhash C Verma; Qiliang Cai; Sabyasachi Haldar; Rajeev Kaul; Mariusz A Wasik; Jaap Middeldorp; Erle S Robertson
Journal:  Virology       Date:  2010-11-19       Impact factor: 3.616

Review 2.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

3.  KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA.

Authors:  Rajesh Ponnusamy; Maxim V Petoukhov; Bruno Correia; Tania F Custodio; Franceline Juillard; Min Tan; Marta Pires de Miranda; Maria A Carrondo; J Pedro Simas; Kenneth M Kaye; Dmitri I Svergun; Colin E McVey
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

4.  Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins.

Authors:  Huaxin Si; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

6.  Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Meir Shamay; Anita Krithivas; Jun Zhang; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

7.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 8.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

9.  Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells.

Authors:  Ying-Liang Duan; Han-Qing Ye; Anamaria G Zavala; Cui-Qing Yang; Ling-Feng Miao; Bi-Shi Fu; Keun Seok Seo; Christian Davrinche; Min-Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 10.  Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence.

Authors:  Katherine M Feeney; Joanna L Parish
Journal:  Proc Biol Sci       Date:  2009-01-20       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.